Obesity and Overweight Prevalence among a Mississippi Low-Income Preschool Population: A Five-Year Comparison

Bonnie L Harbaugh1, Jerome R Kolbo, Elaine F Molaison

  • 1School of Nursing, College of Health, University of Southern Mississippi, 118 College Drive, Box 5095, Hattiesburg, MS 39406-0001, USA.

ISRN Nursing
|October 19, 2011
PubMed

Insights

Childhood obesity rates in Mississippi preschoolers remained stable overall between 2005 and 2010. However, a significant decrease in obesity was observed among 3-year-olds during this period.

Area of Science:

  • Pediatrics
  • Public Health
  • Epidemiology

Background:

  • Childhood obesity is a major global health concern with long-term health implications.
  • Early-onset obesity increases the risk of chronic illnesses and lifetime exposure to related health issues.

Purpose of the Study:

  • To determine 2010 rates of overweight and obesity in low-income Mississippi preschoolers.
  • To compare these rates with 2005 data to identify trends.

Main Methods:

  • Utilized identical measures and complex-stratified sampling designs in both 2005 and 2010.
  • Analyzed data from representative samples of low-income preschoolers in Mississippi.

Main Results:

  • Overall overweight/obesity rates did not significantly change between 2005 (20.6%/17.9%) and 2010 (20.8%/17.0%).
  • A significant decline in obesity rates was observed in 3-year-olds (20.3% to 13.1%, P = 0.035).
  • Findings align with national trends of obesity stabilization in low-income preschool populations.

Conclusions:

  • While overall childhood obesity rates remained stable in this population, specific age groups showed significant changes.
  • The decline in obesity among 3-year-olds suggests potential effectiveness of targeted interventions or changing environmental factors.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Levels of Health Promotion and Illness Prevention01:26

Levels of Health Promotion and Illness Prevention

Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...